Open AccessMedicine
DOI: 10.1016/j.coms.2014.01.001

tlooto Summary

Clinical biomarkers are still needed to improve early detection, predict malignant transformation, and optimize therapies in head and neck squamous cell carcinomas.

Abstract

Head and neck squamous cell carcinoma is the sixth most common cancer worldwide predominately associated with tobacco use. Changing cause and increased incidence in oropharyngeal carcinomas is associated with high-risk types of human papilloma virus and has an improved survival. Optical devices may augment visual oral examination; however, their lack of specificity still warrants tissue evaluation/biopsy. Histologic factors of oral carcinomas are critical for patient management and prognostic determination. Clinical biomarkers are still needed to improve early detection, predict malignant transformation, and optimize therapies.

Citation format

VIGNESWARAN, N.; WILLIAMS, M. Epidemiological trends in head and neck cancer and aids in diagnosis. Oral and Maxillofacial Surgery Clinics of North America, 2014, 26: 123–141.